Ziftomenib Maintenance Post Allo-HCT

Clinical trial NCT06440135 · RECRUITING

Trial details

NCT number: NCT06440135
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Myeloid Leukemia in Remission NPM1 Mutation KMT2A Rearrangement

Start date: 2024-06-11
Primary completion: 2026-09-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.